These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 38690553)

  • 1. Healing condition of WATCHMAN surface 2.5 years after implantation observed in cardiac surgery.
    Yano M; Egami Y; Kondoh H; Nishino M
    Eur Heart J Case Rep; 2024 Apr; 8(4):ytae198. PubMed ID: 38690553
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing?
    Kramer AD; Korsholm K; Jensen JM; Nørgaard BL; Peelukhana S; Herbst T; Horton R; Kar S; Saw J; Alkhouli M; Nielsen-Kudsk JE
    Eur Heart J Cardiovasc Imaging; 2023 Jan; 24(2):250-259. PubMed ID: 36336848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Heart Vessels; 2017 Sep; 32(9):1137-1143. PubMed ID: 28477098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
    Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of 3-Dimensional Computed Tomographic Image Guidance to WATCHMAN Implantation and Impact on Early Operator Learning Curve: Single-Center Experience.
    Wang DD; Eng M; Kupsky D; Myers E; Forbes M; Rahman M; Zaidan M; Parikh S; Wyman J; Pantelic M; Song T; Nadig J; Karabon P; Greenbaum A; O'Neill W
    JACC Cardiovasc Interv; 2016 Nov; 9(22):2329-2340. PubMed ID: 27884358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model.
    Kar S; Hou D; Jones R; Werner D; Swanson L; Tischler B; Stein K; Huibregtse B; Ladich E; Kutys R; Virmani R
    JACC Cardiovasc Interv; 2014 Jul; 7(7):801-9. PubMed ID: 25060026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postapproval Community Hospital Experience in the United States with Left Atrial Appendage Closure Device (Watchman).
    Khalighi K; Sharma M; Masih R; Levin V
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2538-2542. PubMed ID: 29857929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography measurement of the left atrial appendage for optimal sizing of the Watchman device.
    Xu B; Betancor J; Sato K; Harb S; Abdur Rehman K; Patel K; Kumar A; Cremer PC; Jaber W; Rodriguez LL; Schoenhagen P; Wazni O
    J Cardiovasc Comput Tomogr; 2018; 12(1):50-55. PubMed ID: 29223726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transesophageal Echocardiography-Guided WATCHMAN Implantation Without Contrast Use: A Three-Year, Single-Center Experience.
    Saad Shaukat MH; Patel H; Alimohammad R; DeLago A
    Cureus; 2020 May; 12(5):e8375. PubMed ID: 32626619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage.
    Hucker WJ; Cohen JA; Gurol ME; Heist EK; Gianni C; Galvin J; Atkins D; Bommana S; Di Biase L; Ruskin J; Mohanty S; Horton R; Lakkireddy D; Natale A; Mansour M
    J Interv Card Electrophysiol; 2020 Nov; 59(2):415-421. PubMed ID: 31833012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New WATCHMAN Sizing Algorithm Utilizing Cardiac CTA.
    Nadeem F; Igwe C; Stoycos S; Jaswaney R; Tsushima T; Al-Kindi S; Bansal E; Fares A; Dallan L; Patel S; Rajagopalan S; Arruda M; Filby S; Bezerra H
    Cardiovasc Revasc Med; 2021 Dec; 33():13-19. PubMed ID: 33526392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage closure device implantation in patients at very high risk for stroke.
    Hutt E; Wazni OM; Kaur S; Saliba WI; Tarakji KG; Kapadia S; Aguilera J; Barakat AF; Abdallah M; Jaber W; Rasmussen P; Hussain S; Uchino K; Wisco D; Lindsay BD; Kanj M; Hussein AA
    Heart Rhythm; 2020 Jan; 17(1):27-32. PubMed ID: 31302250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of Complete Endothelialization of a Watchman Device 3 Years Post-Implantation.
    Batnyam U; Tuluca A; Witzke CF; Greenspan AM; Mainigi SK
    JACC Case Rep; 2021 Feb; 3(2):319-321. PubMed ID: 34317527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The WATCHMAN device and post-implantation anticoagulation management. A review of key studies and the risk of device-related thrombosis.
    Magdi M; Renjithal SLM; Mubasher M; Mostafa MR; Lathwal Y; Mukuntharaj P; Mohamed S; Alweis R; Tan BE; Baibhav B
    Am J Cardiovasc Dis; 2021; 11(6):714-722. PubMed ID: 35116184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION.
    Paitazoglou C; Meincke F; Bergmann MW; Eitel I; Fink T; Vireca E; Wohlmuth P; Veliqi E; Willems S; Markiewicz A; Grygier M
    Heart Rhythm; 2022 Jun; 19(6):917-926. PubMed ID: 35181483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed Tomography Scan Evidence for Left Atrial Appendage Short-Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing.
    Mahmoudi K; Galea R; Elhadad S; Temperli F; Sebag F; Gräni C; Rezine Z; Roten L; Landolff Q; Brugger N; Masri A; Räber L; Amabile N
    J Am Heart Assoc; 2023 Sep; 12(17):e030037. PubMed ID: 37609989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAUDE Database Analysis of Post-Approval Outcomes following Left Atrial Appendage Closure with the Watchman Device.
    Ledesma PA; Uzomah UA; Yu X; Shaqdan A; Khaloo P; Galvin J; Mansour M; Ptaszek LM; Ruskin JN
    Am J Cardiol; 2021 Aug; 152():78-87. PubMed ID: 34116792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.